ࡱ> FI  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEHRoot Entry F@K"GWorkbookSummaryInformation(DocumentSummaryInformation8t \ppzucco Ba==ZxCalibri1>Calibri1>Calibri1>Calibri14Calibri1<Calibri1?Calibri1h>Cambria1Calibri15Calibri"$"#,##0_);\("$"#,##0\)!"$"#,##0_);[Red]\("$"#,##0\)""$"#,##0.00_);\("$"#,##0.00\)'""$"#,##0.00_);[Red]\("$"#,##0.00\)7*2_("$"* #,##0_);_("$"* \(#,##0\);_("$"* "-"_);_(@_).))_(* #,##0_);_(* \(#,##0\);_(* "-"_);_(@_)?,:_("$"* #,##0.00_);_("$"* \(#,##0.00\);_("$"* "-"??_);_(@_)6+1_(* #,##0.00_);_(* \(#,##0.00\);_(* "-"??_);_(@_) 0.0\ % 0.00\ %\$#,##0;"($"#,##0\)                                                                       ff + ) , *     P  P        `            a   | ||D |D |D |D | | | |||H}A} 00\);_(*ef;_(@_) }A} 00\);_(*ef;_(@_) }A} 00\);_(*ef;_(@_) }A} 00\);_(*ef;_(@_) }A} 00\);_(*ef;_(@_) }A} 00\);_(*ef ;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*L ;_(@_) }A} 00\);_(*23;_(@_) }A} 00\);_(*23;_(@_) }A} 00\);_(*23;_(@_) }A} 00\);_(*23;_(@_) }A}  00\);_(*23;_(@_) }A}! 00\);_(*23 ;_(@_) }A}" 00\);_(*;_(@_) }A}# 00\);_(*;_(@_) }A}$ 00\);_(*;_(@_) }A}% 00\);_(*;_(@_) }A}& 00\);_(*;_(@_) }A}' 00\);_(* ;_(@_) }A}( 00\);_(*;_(@_) }}) }00\);_(*;_(@_)    }}* 00\);_(*;_(@_) ??? ??? ??? ???}-}/ 00\);_(*}A}0 a00\);_(*;_(@_) }A}1 00\);_(*;_(@_) }A}2 00\);_(*?;_(@_) }A}3 00\);_(*23;_(@_) }-}4 00\);_(*}}5 ??v00\);_(*̙;_(@_)    }A}6 }00\);_(*;_(@_) }A}7 e00\);_(*;_(@_) }x}800\);_(*;_(  }}9 ???00\);_(*;_(??? ???  ??? ???}-}; 00\);_(*}U}< 00\);_(*;_( }-}= 00\);_(* 20% - Accent1M 20% - Accent1 ef % 20% - Accent2M" 20% - Accent2 ef % 20% - Accent3M& 20% - Accent3 ef % 20% - Accent4M* 20% - Accent4 ef % 20% - Accent5M. 20% - Accent5 ef % 20% - Accent6M2 20% - Accent6  ef % 40% - Accent1M 40% - Accent1 L % 40% - Accent2M# 40% - Accent2 L湸 % 40% - Accent3M' 40% - Accent3 L % 40% - Accent4M+ 40% - Accent4 L % 40% - Accent5M/ 40% - Accent5 L % 40% - Accent6M3 40% - Accent6  Lմ % 60% - Accent1M 60% - Accent1 23 % 60% - Accent2M$ 60% - Accent2 23ٗ % 60% - Accent3M( 60% - Accent3 23֚ % 60% - Accent4M, 60% - Accent4 23 % 60% - Accent5M0 60% - Accent5 23 %! 60% - Accent6M4 60% - Accent6  23 % "Accent1AAccent1 O % #Accent2A!Accent2 PM % $Accent3A%Accent3 Y % %Accent4A)Accent4 d % &Accent5A-Accent5 K % 'Accent6A1Accent6  F %(Bad9Bad  %) Calculation Calculation  }% * Check Cell Check Cell  %????????? ???+ Comma,( Comma [0]-&Currency.. Currency [0]/Explanatory TextG5Explanatory Text % 0Good;Good  a%1 Heading 1G Heading 1 I}%O2 Heading 2G Heading 2 I}%?3 Heading 3G Heading 3 I}%234 Heading 49 Heading 4 I}% 5InputuInput ̙ ??v% 6 Linked CellK Linked Cell }% 7NeutralANeutral  e%"Normal 8Noteb Note   9OutputwOutput  ???%????????? ???:$Percent ;Title1Title I}% <TotalMTotal %OO= Warning Text? Warning Text %XTableStyleMedium9PivotStyleLight1683ffff̙̙3f3fff3f3f33333f33333\`gHTop Drugs by Volume  ;o(KRankDrugTier Therapy ClassRx Count% of AllLIPITORTier 2*HMG COA REDUCTASE INHIBITORS** LISINOPRILTier 1*ACE INHIBITORS** SIMVASTATIN AZITHROMYCIN*AZITHROMYCIN**LEVOTHYROXINE SODIUM*THYROID HORMONES**LEXAPRO2*SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS)**HYDROCODONE/ACETAMINOPHEN*OPIOID COMBINATIONS**PANTOPRAZOLE SODIUM*PROTON PUMP INHIBITORS**ATENOLOL!*BETA BLOCKERS CARDIO-SELECTIVE** SYNTHROIDSERTRALINE HCLNEXIUMAMLODIPINE BESYLATE*CALCIUM CHANNEL BLOCKERS** SINGULAIR*LEUKOTRIENE MODULATORS** ALPRAZOLAM*BENZODIAZEPINES** AMOXICILLIN*AMINOPENICILLINS** PREDNISONE*GLUCOCORTICOSTEROIDS**HYDROCHLOROTHIAZIDE(*THIAZIDES AND THIAZIDE-LIKE DIURETICS**CRESTORTier 3FLUOXETINE HCL METFORMIN HCL *BIGUANIDES**ZOLPIDEM TARTRATE*NON-BARBITURATE HYPNOTICS**METOPROLOL SUCCINATE ERCYMBALTA7*SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIS)** LORAZEPAMMETOPROLOL TARTRATE CLONAZEPAM$*ANTICONVULSANTS - BENZODIAZEPINES**LOESTRIN 24 FE$*COMBINATION CONTRACEPTIVES - ORAL**FEXOFENADINE HCL *ANTIHISTAMINES - NON-SEDATING**VYTORIN%*ANTIHYPERLIPIDEMICS - COMBINATIONS**OXYCODONE/ACETAMINOPHENRAMIPRILAMPHETAMINE/DEXTROAMPHETA*AMPHETAMINES**CITALOPRAM HYDROBROMIDEDIOVAN&*ANGIOTENSIN II RECEPTOR ANTAGONISTS** ALLOPURINOL*GOUT AGENTS**ORTHO TRI-CYCLEN LO ADVAIR DISKUS*SYMPATHOMIMETICS** GABAPENTIN*ANTICONVULSANTS - MISC.**ONETOUCH ULTRA TEST STRIP*Diagnostic Tests**ZETIA/*INTESTINAL CHOLESTEROL ABSORPTION INHIBITORS**METHYLPREDNISOLONE EFFEXOR XR LOVASTATINWARFARIN SODIUM*COUMARIN ANTICOAGULANTS**TRIAMTERENE/HYDROCHLOROTH*DIURETIC COMBINATIONS**LISINOPRIL/HYDROCHLOROTHI *ANTIHYPERTENSIVE COMBINATIONS**AMOXICILLIN/POTASSIUM CLA*PENICILLIN COMBINATIONS** PROAIR HFABENICARPOLYETHYLENE GLYCOL 3350*LAXATIVES - MISCELLANEOUS**BUPROPION HCL XL*ANTIDEPRESSANTS - MISC.**DOXYCYCLINE HYCLATE*TETRACYCLINES** OMEPRAZOLEFLUTICASONE PROPIONATE*CORTICOSTEROIDS - TOPICAL***NASAL STEROIDS**NASONEXDIAZEPAMVAGIFEM*VAGINAL ESTROGENS** DIOVAN HCTALENDRONATE SODIUM*CALCIUM REGULATORS - MISC.** IBUPROFEN1*NONSTEROIDAL ANTI-INFLAMMATORY AGENTS (NSAIDS)**LEVAQUIN*FLUOROQUINOLONES** LANSOPRAZOLESULFAMETHOXAZOLE/TRIMETHO&*ANTI-INFECTIVE MISC. - COMBINATIONS** LAMOTRIGINECIPROFLOXACIN HCL*OPHTHALMIC ANTI-INFECTIVES** FLUCONAZOLE *IMIDAZOLE-RELATED ANTIFUNGALS** FUROSEMIDE*LOOP DIURETICS**PAROXETINE HCLPLAVIX"*PLATELET AGGREGATION INHIBITORS**CYCLOBENZAPRINE HCL*CENTRAL MUSCLE RELAXANTS** CEPHALEXIN"*CEPHALOSPORINS - 1ST GENERATION** RISPERIDONE*BENZISOXAZOLES**METFORMIN HCL ER TRAZODONE HCL*MODIFIED CYCLICS**NAPROXENAMITRIPTYLINE HCL*TRICYCLIC AGENTS**XALATAN*PROSTAGLANDINS - OPHTHALMIC**OCELLACELEBREX VENTOLIN HFA TRI-SPRINTEC MELOXICAMLUNESTA VIVELLE-DOT *ESTROGENS**AVODART*PROSTATIC HYPERTROPHY AGENTS**LYRICA FLOVENT HFA*STEROID INHALANTS**YAZPRISTIQPROPRANOLOL HCL*BETA BLOCKERS NON-SELECTIVE**SUMATRIPTAN SUCCINATE*SEROTONIN AGONISTS**ACIPHEX OXYCODONE HCL*OPIOID AGONISTS**BUTALBITAL/APAP/CAFFEINE*ANALGESIC COMBINATIONS** PROVENTIL HFATRICOR*FIBRIC ACID DERIVATIVES**PENICILLIN V POTASSIUM*NATURAL PENICILLINS**PRAVASTATIN SODIUMSPIRONOLACTONE*POTASSIUM SPARING DIURETICS**Total of top DrugsRemaining Drugs Grand TotalBidder's Formulary Status@, ,Z --.Y;//0kZ1&223S;445L G6 6 7S 8 8S 9 9 cc PK![Content_Types].xmlj0Eжr(΢Iw},-j4 wP-t#bΙ{UTU^hd}㨫)*1P' ^W0)T9<l#$yi};~@(Hu* Dנz/0ǰ $ X3aZ,D0j~3߶b~i>3\`?/[G\!-Rk.sԻ..a濭?PK!֧6 _rels/.relsj0 }Q%v/C/}(h"O = C?hv=Ʌ%[xp{۵_Pѣ<1H0ORBdJE4b$q_6LR7`0̞O,En7Lib/SeеPK!kytheme/theme/themeManager.xml M @}w7c(EbˮCAǠҟ7՛K Y, e.|,H,lxɴIsQ}#Ր ֵ+!,^$j=GW)E+& 8PK!ÄA theme/theme/theme1.xmlYOoE#F{oc'NjGuرhF[xw;23NjHH q Jĥ|@_73xM6{o~(fIyWk"޽aJCR$'Mnlu"^T$}*OIB.bQn̖kC 0>ACMȉ<&J &M5BNe tY>?#!mfKx=[Ԃu}ˆ ~umoLz^W/}ةLo;9iwk/_tV[,ac߬56YvYp1ϡAz 9ۮ7ެe ."Zk1~EȰ RӔ/x$( :7vʗsSj{"bF^x^xz?>~,ɸ7Gg_zy5^|?}V I򋧿>O~I|SQ>19D{<Ÿ8ߊaG@tOE*\ʻ/ yToN:"1Q(v; y4<$jbRa|PŻǴI Y3wJG݈8b2(<& QHT^w/B(`Z!94[Mc˴j`jG7;Q]o YC5*CocU 9 IQ/ RV+`%*;æWѼ9/#~7qZ$*cߓrUngN>%OOi Dh[BvoLJƌB6>p&>w O]>_x.eywQ,5,^<ؾt&9 ԔEЇIIqhJ#f6kAS&2D)p3ӕ5teO`jvzEOG)9cshger-# ~fu-ԙՍh&9܊- 6 AлY3hX"M$#Fz6#b.w*lyhĭɾ̮]nR3+=,)'Kak.zi X 8Ka6!_ 5[ M܆< kW Ds/Z/j@&8?&5- C⫲K3Zw1K|D!`~J0A?Uֶy&,Xg1K#[y$[BTV)bBRvVt=낕@[\׶Dž8d4~_@`rx \kp*O69mY&ԧ HE]HKN!Vj%2BƣJԊ=" u\ӵC&Y0>g4&oN)j rihr"VTU,koy#ŬjQJpRk3܎Ws;ɢ!JT~u "֠ۀW_ Nq֙4)ڬuZˋw֒TvќXHegvtm,{2Da*20V=CoOQ2'@C8D.IrG[Ȥiࠆ)d͛|?&f9>b|w##(ɇ"C *_p=ce΂aenv*Wm瓗{varAˇ$IDpKs6* ʢG0egAnlCYt֏$Ysă)2|FS` uz'Xr*󠍒F`Bi m/Ҷj9Xrmox86tFo˜ b`>ASDbƟPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 +_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!ÄA theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK]    qkRyap  do@_*+%&$U"?'|6i?(V#?)쳀M?M\\citywork\CMPP10dXXdPcK@o **$**$o @* 3*$ 000000004!*4!*2 dd@ ? ?XX0J,X< XXXX OffdPcKP@0dPcK'@dPcK N@Confidential 1"dXXUPPPPP?UPPPPP?&TPU} } } (}  } 8}  } } Iq@f@0@0@0@0@0@@0@ 0@ 0@ 0@ @ 0@0@0@0@0@0@0@0@0@@0@0@0@@0@0@0@0@0@>>>>>>> ? ? ? ? ? ? G~ @ A A A~ BnCGȼN?>~ @ A A A ~ B Ce@?>~ @ A A A~ B C /S B?>~ @ A A A~ B CƱ ?>~ @ A A A~ BJ CG+*?>~ @ A A A~ B C睐?>~ @ A A A~ BC3ʱ?>~ @" A A A~ Bz CŜ =?? >~ @& A A A~ B> C`d? >~ @* A A A~ B C1#{? >~ @. A A A~ Bz CL? >~ @2 A A A~ Bv CD? >~ @6 A A A~ BZC,IUY$?>~ @: A A A~ BC'fS;?>~ @> A A A!~ BC`{v?>~ @> A" A A#~ BC`{v?>~ @F A$ A A%~ BC݇#?>~ @J A& A A'~ BNCES?>~ @N A( A A~ BC<;QH?>~ @N A( A) A~ BvCSf8sJ?>~ @N A* A A~ BJCU{D?>~ @V A+ A A,~ B>CN?>~ @Z A- A A.~ B*C)ς?>~ @^ A/ A A~ BC~06/?>~ @b A0 A A1~ BbCm)?>~ @b A2 A A!~ BbCm)?>~ @j A3 A A~ BZC3ʱ?>~ @n A4 A A5~ BC^r}?>~ @r A6 A A7~ BCL}?>~ @v A8 A A9~ BC/}?>Dvlbbbbbbbbbbbbbbbbbbbbbbbbbbbbbb 0@!0@"0@#0@$@%0@&0@'0@(0@)0@*0@+@,0@-@.0@/0@00@10@20@30@40@50@60@70@80@90@:0@;0@<0@=0@>0@?0@~ @z A: A) A;~ B CByz? >~ !@~ !A< !A !A~ !B!C="Iy?!>~ "@ "A= "A "A ~ "BJ"CQF0w?">~ #@ #A> #A #A?~ #B#Ca3uv?#>~ $@ $A@ $A $A~ $B$CdXv?$>~ %@ %AA %A %AB~ %B%CdXv?%>~ &@ &AC &A &AD~ &B&Ctou?&>~ '@ 'AE 'A 'A7~ 'B'Ctou?'>~ (@ (AF (A (AG~ (B(C;։)Kt?(>~ )@ )AH )A )AI~ )B)C5as?)>~ *@ *AJ *A *AK~ *B*Cu s?*>~ +@ +AL +A) +AM~ +B+Cr?+>~ ,@ ,AN ,A ,A%~ ,B,C0x.xr?,>~ -@ -AO -A -A1~ -B-Cn=r?->~ .@ .AP .A .A~ .B~.CƱ r?.>~ /@ /AQ /A /AR~ /Bj/C*Ixq?/>~ 0@ 0AS 0A 0AT~ 0Bb0Ci}QTq?0>~ 1@ 1AU 1A 1AV~ 1BV1Cp?1>~ 2@ 2AW 2A 2AX~ 2BR2CRp?2>~ 3@ 3AY 3A 3AG~ 3BR3CRp?3>~ 4@ 4AZ 4A) 4AB~ 4BN4Cˡbp?4>~ 5@ 5A[ 5A 5A\~ 5BF5CD4?p?5>~ 6@ 6A] 6A 6A^~ 6B:6C,t0p?6>~ 7@ 7A_ 7A 7A`~ 7B:7C,t0p?7>~ 8@ 8Aa 8A 8A~ 8B28Cm)o?8>~ 9@ 9Ab 9A 9Ac~ 9B9Chl?9>~ :@ :Ab :A :Ad~ :B":C> o?:>~ ;@ ;Ae ;A ;Ad~ ;B*;C?ֻjwo?;>~ <@ <Ae <A) <Ad~ <B<C/><>~ =@ =Af =A =A!~ =B*=C?ֻjwo?=>~ >@ >Ag >A >Ah~ >B">C> o?>>~ ?@ ?Ai ?A ?AV~ ?B?CxSn??>Dlbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbb@0@A@B0@C0@D0@E0@F0@G0@H0@I0@J0@K@L0@M0@N0@O0@P0@Q0@R@S0@T0@U0@V@W0@X0@Y@Z0@[0@\0@]0@^0@_0@~ @@ @Aj @A @Ak~ @B@CՅ.n?@>~ A@ AAl AA AAm~ ABACC#m?A>~ B@ BAn BA BAo~ BBBCC#m?B>~ C@ CAp CA CA~ CBCCm}גl?C>~ D@ DAp DA) DA~ DBDC/?D>~ E@ EAq EA EAr~ EBECQl?E>~ F@ FAs FA FAI~ FBFCu3Fl?F>~ G@  GAt GA GAo~ GBGCSf8sj?G>~ H@  HAt HA HAu~ HBHC$)޺)?H>~ I@  IAv IA IAw~ IBIC l?I>~ J@ JAx JA JAy~ JBJC(tk?J>~ K@ KAz KA KA~ KBKC V"k?K>~ L@ LA{ LA LA|~ LBLC V"k?L>~ M@ MA} MA MA~~ MBMC#*j?M>~ N@" NA NA NA~ NBNCSf8sj?N>~ O@" OA OA OA~ OBOCSf8sj?O>~ P@* PA PA PA,~ PBPC yi?P>~ Q@* QA QA QA~ QBQC yi?Q>~ R@2 RA RA RAm~ RBRC\$@i?R>~ S@6 SA SA SA~ SBSCV5h?S>~ T@6 TA TA TA~ TBTCV5h?T>~ U@> UA UA UA7~ UBUC9V=h?U>~ V@B VA VA) VAm~ VBVC)>eh?V>~ W@B WA WA) WAG~ WBWC)>eh?W>~ X@J XA XA XA7~ XBXC^B~+h?X>~ Y@N YA YA YAm~ YBYCQF0g?Y>~ Z@R ZA ZA ZA.~ ZBnZC9V=H?Z>~ [@R [A [A) [A.~ [B.[CĴa?[>~ \@V \A \A \A~ \B\CKcWg?\>~ ]@Z ]A ]A ]A~ ]B]C[FBf?]>~ ^@^ ^A ^A) ^AI~ ^B^C_f?^>~ _@b _A _A _A~ _B_CF4h $f?_>Dlbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbb`0@a@b0@c0@d0@e0@f0@g0@h0@i0@j0@k0@l0@mG@nG@oG@p~ `@b `A `A `A7~ `B`CF4h $f?`>~ a@j aA aA aA1~ aB~aCÜp\ee?a>~ b@j bA bA bA~ bB~bCÜp\ee?b>~ c@r cA cA cA~ cBzcCtoe?c>~ d@v dA dA) dA~ dBndCmd?d>~ e@v eA eA eA~ eBneCmd?e>~ f@~ fA fA fA~ fBbfCy d?f>~ g@ gA gA gAG~ gBZgCr c?g>~ h@ hA hA hA~ hBVhCt۞&L'C?h>~ i@ iA iA) iA~ iBiC3xo]?i>~ j@ jA jA jA~ jBVjC5ac?j>~ k@ kA kA kA~ kBVkC5ac?k>~ l@ lA lA lA~ lBVlC5ac?l> mDDD mD~ mEXmFZ}J?m> nDDD nD~ nEnFLk3?n> oDDD oDoE^1Fo>p>>>>>>>&4@bbbbbbbbbbbbbHH>>@>:ggD  Oh+'0@Hd t Spurgeon, Josephpzucco@@r@՜.+,D՜.+,$HP X`hp x  Top Drugs by Volume   Worksheets Named RangesP <D_NewReviewCycle F&Microsoft Office Excel 2003 WorksheetBiff8Excel.Sheet.89qCompObj r